Synapmed

Synapmed is a science-led, AI-native, full-service CRO transforming drug safety, compliance, and clinical development across the product lifecycle. The organization supports programs from pre-clinical through post-marketing across 40+ countries, operating in 60+ languages, and spanning ten plus therapeutic and rare-disease areas. With ISO-certified quality systems and a unified, inspection-ready operating model, Synapmed integrates clinical operations, regulatory affairs, pharmacovigilance, medical affairs, real-world evidence, and market access within a single connected platform, ensuring end-to-end traceability, auditability, and regulatory compliance across all deliverables. 

In parallel, Synapmed is pioneering the future of medical AI by contributing real-world, high-impact use cases to the training of one of the world’s most advanced large language models. We have recently supported a top-20 global pharmaceutical company in analyzing data from 50,000+ patients across 11 rare diseases, using AI to uncover treatment and biomarker patterns and enable up to 60% faster, data-driven decision-making.